Work

Durability of Immunity and Safety of RSV Vaccination in High-Risk Transplant Recipients

Year: 2026

Type: article

Study design: Clinical Trial

Abstract: This nonrandomized clinical trial examines humoral and cell-mediated immunity and longer-term safety following vaccination for respiratory syncytial virus (RSV) among recipients of lung transplant and allogeneic hematopoietic cell transplant.

Source: JAMA Network Open

DOI: 10.1001/jamanetworkopen.2026.41946

Authors: Victoria G. Hall, Adrian A. Alexander, Madeline R. Kern-Smith, Faranak Mavandadnejad, Sarayna Bala, Xiaoqing Dang, Rujun Kang, Sapna Humar, Poramed Winichakoon, Rochelle Johnstone, Ailya Salman, Meghan Aversa, Igor Novitzky-Basso, Roni Bitterman, Pascal M. Lavoie, Deepali Kumar, Jonas Mattsson, Victor H. Ferreira

Institutions: University Health Network, University of Toronto, Alberta Health Services, University of Calgary, Foothills Medical Centre, University of British Columbia, BC Children's Hospital Research Institute, Chiang Mai University, Princess Margaret Cancer Centre

Language: English

Topic: Respiratory viral infections research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

OpenAlex ID: W7225390758

FWCI:

Cites: 9

Cited by:

Related to: 10